Bill Text: US HB3536 | 2017-2018 | 115th Congress | Introduced
Bill Title: To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.
Spectrum: Partisan Bill (Democrat 8-0)
Status: (Introduced - Dead) 2017-08-04 - Referred to the Subcommittee on Health. [HB3536 Detail]
Download: US_Congress-2017-HB3536-Introduced.pdf